Drug
Romosozumab clinical trials
Also written Evenity and AMG 785.
- studies test it
- 37
- open now
- 7
- in phase 3
- 10
- first study started
- 2006
Keep track of what changes. Save the romosozumab studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
36 studies that test it; most in 2021 (7); 1 more planned to start later
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 3 |
| 2010 | 2 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 7 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 9
- Phase 2
- 8
- Phase 3
- 10
- Phase 4
- 10
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 22 · Other 15
Amgen (21) · Tuen Mun Hospital (3) · Memorial Sloan Kettering Cancer Center (2) · Susan L. Greenspan (1) · James J. Peters Veterans Affairs Medical Center (1) · UCB Biopharma SRL (1) · VA Office of Research and Development (1) · Northwestern University (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses romosozumab is read from its arms, and is right about nine times in ten.
Testing it · 37
- Comparing the Extent to Which Romosozumab (AMG 785) is Made Available in the Body When Administered as a Single SC Injection or as 2 SC InjectionsRecruitingPhase 1AmgenNCT07811999Written as Romosozumab
- A Study of Romosozumab in People With Breast Cancer and OsteoporosisRecruitingPhase 2Memorial Sloan Kettering Cancer CenterNCT07776613Written as Romosozumab
- Sequential Treatment With Romosozumab Followed by Denosumab vs. Zoledronic Acid for Gains in HIP BMDNot yet recruitingPhase 4Sahlgrenska University HospitalNCT07772609Written as Romosozumab
- Romosozumab Versus Denosumab In Glucocorticoid-induced Osteoporosis: An Extended Observation Of a Clinical Trial at 6 YearsNot yet recruitingPhase 4Tuen Mun HospitalNCT07757373Written as Romosozumab
- The Optimised Use of Romozosumab StudyRecruitingPhase 4University of AarhusNCT06059222Written as Romosozumab
- Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic AmenorrheaRecruitingPhase 3Massachusetts General HospitalNCT06533865Written as Romosozumab
- Romosozumab and Denosumab, Alone or Combined, in Postmenopausal OsteoporosisRecruitingPhase 4National Taiwan University HospitalNCT07283887Written as Romosozumab
- A Study of Romosozumab (EVENITY®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture.CompletedPhase 4AmgenNCT06079476Written as Romosozumab
- A Study to Test the Efficacy, Safety and Tolerability of Romosozumab Treatment in Postmenopausal Chinese Women With OsteoporosisCompletedPhase 3UCB Biopharma SRLNCT05067335Written as Romosozumab
- Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCICompletedPhase 2VA Office of Research and DevelopmentNCT04232657Written as Romosozumab
- Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery OutcomesWithdrawnPhase 2University of PittsburghNCT06973109Written as Romosozumab
- Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis ImperfectaActive, not recruitingPhase 3AmgenNCT05972551Written as Romosozumab
- Romosozumab Versus Denosumab in Glucocorticoid-induced Osteoporosis: an Extended Observation of a Randomized Controlled Trial at 48 MonthsCompletedPhase 4Tuen Mun HospitalNCT06472050Written as Romosozumab
- Romosozumab Use to Build Skeletal IntegrityActive, not recruitingPhase 4Susan L. GreenspanNCT05058976Written as Romosozumab
- A Study of Romosozumab in Women With Multiple Myeloma and OsteoporosisActive, not recruitingPhase 1Memorial Sloan Kettering Cancer CenterNCT05775094Written as Romosozumab
- Romosozumab in Women With Chronic SCICompletedPhase 2Northwestern UniversityNCT04708886Written as Romosozumab
- Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCIActive, not recruitingPhase 4James J. Peters Veterans Affairs Medical CenterNCT05101018Written as Romosozumab
- Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With OsteoporosisCompletedPhase 3AmgenNCT01631214Written as Romosozumab
- Romosozumab Versus Denosumab for Osteoporosis in Long-term Glucocorticoid UsersCompletedPhase 4Tuen Mun HospitalNCT04091243Written as Romosozumab
- Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With OsteoporosisCompletedPhase 3AmgenNCT01575834Written as Romosozumab
See all 37 studies that test romosozumab →
Given in every arm · 3 — romosozumab is usual care beside what is tested
- Combined Anabolic TherapyRecruitingPhase 4Massachusetts General HospitalNCT06558188Written as Romosozumab
- Anabolic Therapy in Postmenopausal OsteoporosisActive, not recruitingPhase 4Massachusetts General HospitalNCT05010590Written as Romosozumab
- Romosozumab/Denosumab Study for Premenopausal IOPActive, not recruitingPhase 2Columbia UniversityNCT04800367Written as Romosozumab Prefilled Syringe [Evenity]
As the comparator · 2 — what is tested is compared with romosozumab
- Compare the Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of SAL023 and Italy-Manufactured Evenity in Healthy SubjectsEnrolling by invitationPhase 1Shenzhen Salubris Pharmaceuticals Co., Ltd.NCT07384104Written as Romosozumab
- Efficacy of Romosozumab and Denosumab Combined Treatment in Postmenopausal Osteoporosis Patients with Multiple Fragility FracturesNot yet recruitingPhase 4Marmara UniversityNCT06720350Written as Romosozumab Prefilled Syringe [Evenity]
Codes
What other systems call romosozumab · ClinicalTrials.gg INT005797
- MeSH (NLM) C557282romosozumabConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 3VHF2ZD92JROMOSOZUMABConfirmed FDA, NLM, Wikidata
- RxNorm 2123126One source FDA
- Wikidata Q7363297RomosozumabConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152246RomosozumabOne source FDA
- DrugBank DB11866One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C557282 | romosozumab | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 3VHF2ZD92J | ROMOSOZUMAB | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2123126 | — | One source FDA |
| Wikidata | Q7363297 | Romosozumab | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152246 | Romosozumab | One source FDA |
| DrugBank | DB11866 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.